Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» kidney disease
kidney disease
Amgen's AMG 416 Succeeds in Phase III, Shares Up
Yahoo/Zacks.com
Mon, 07/21/14 - 03:38 pm
Amgen
AMG 416
kidney disease
IPO Preview: NephroGenex
Seeking Alpha
Fri, 02/7/14 - 09:28 am
IPOs
NephroGenex
kidney disease
AstraZeneca Boasts of Pipeline as Analysts See Deal Ahead
Bloomberg
Fri, 02/7/14 - 09:22 am
AstraZeneca
roxadustat
kidney disease
non-small cell lung cancer
AZD9291
What To Know About Questcor Pharmaceuticals' Most Important Drug
Motley Fool
Thu, 01/23/14 - 09:37 am
Questcor Pharmaceuticals
Acthar
multiple sclerosis
kidney disease
rheumatology
Amgen spinoff Atara cranks its Series B up to $52M
Fierce Biotech
Fri, 01/10/14 - 06:58 pm
Amgen
Atara
Series B
oncology
kidney disease
Evotec, AstraZeneca in Kidney Disease Alliance
Contract Pharma
Tue, 10/22/13 - 08:16 am
kidney disease
AstraZeneca
Evotec
Amgen Benefits From Affymax Recall
Seeking Alpha
Tue, 03/5/13 - 11:58 am
Amgen
Affymax
recalls
Omontys
Takeda
kidney disease
Zerenex Kidney Treatment: A Game Changer for Keryx Biopharmaceuticals
Motley Fool
Mon, 02/11/13 - 08:16 am
Keryx
Zerenex
kidney disease
A Closer Look At Keryx Biopharmaceuticals' Phase III Result Announcement
Seeking Alpha
Tue, 02/5/13 - 10:28 am
Keryx
kidney disease
Zerenex
Keryx shares more than doubles on kidney drug data
Yahoo/AP
Sat, 02/2/13 - 11:56 am
Keryx
Zerenex
kidney disease
Keryx shares soar on kidney drug results
Yahoo/AP
Mon, 01/28/13 - 12:20 pm
Keryx
Zerenex
kidney disease
Will Kidney Disease Drug Success Push This Stock Higher?
Motley Fool
Mon, 01/21/13 - 11:35 am
Keryx
Zerenex
kidney disease
Is Keryx Spring Loaded on Zerenex?
Motley Fool
Mon, 12/24/12 - 10:31 am
kidney disease
Zerenex
Keryx
Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
Business Wire
Sun, 11/4/12 - 10:54 am
Otsuka
Tolvaptan
autosomal dominant polycystic kidney disease
kidney disease
Abbott, Reata kidney disease drug trial stopped
Reuters
Thu, 10/18/12 - 11:42 am
Abbott
Reata
kidney disease
Bardoxolone
AbbVie
Humira
A Fresh Look At KERX; High Odds For Zerenex Phase III Success
Yahoo/Reuters
Fri, 10/12/12 - 10:59 am
Keryx
Zerenex
kidney disease
Amgen's Sensipar fails in late-stage trial
Pharma Times, UK
Mon, 06/11/12 - 01:04 pm
Amgen
Sensipar
kidney disease
A Little Confidence Goes a Long Way
Motley Fool
Sat, 04/28/12 - 11:40 am
Keryx
Aeterna Zentaris
Zerenex
renal disease
kidney disease
Torii Pharmaceutical
FDA Turns Down Expanded Use of Mercks’ Vytorin and Zetia
Bloomberg
Wed, 01/25/12 - 09:32 am
FDA
Vytorin
Merck
Zetia
kidney disease
FDA panel backs expanded use of Merck's Vytorin
Yahoo/AP
Thu, 11/3/11 - 08:50 am
FDA
Merck
Vytorin
kidney disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »